Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (19877)	4/30/1998 9:41:00 PM
From: Machaon	Read Replies (2) \| Respond to of 32384

<< Bob, 130 posts is enough to still be correct. >> A Panretin Gel NDA for KS might just be what the doctor ordered for LGND's share price. A lot is riding on Targretin and Panretin being successful. Perhaps the market is just waiting for a little more substantiation, such as the NDA, due to LGND's $600+ million Cap. Of course, then, after that, the final verdict is up to the FDA. Walter, your "$20 by 20,000 posts" is looking a little shaky. Are you ready for the obnoxious rants from tonyt, or his low IQ stooge, if you miss your prediction? Regards, Bob